tranexamic acid

Preferred Label : tranexamic acid;

MeSH definition : Antifibrinolytic hemostatic used in severe hemorrhage.;

MeSH synonym : amcha; trans-4-(aminomethyl)cyclohexanecarboxylic acid; t-amcha; amca;

CISMeF synonym : acid, tranexamic;

MeSH hyponym : amchafibrin; exacyl; ugurol; transamin; KABI 2161; cyklokapron; spotof; anvitoff;

MeSH CAS label : cyclohexanecarboxylic acid, 4-(aminomethyl)-, trans-;

MeSH Related Number : 1197-18-8 (Tranexamic acid);

Registry Number MeSH : 1197-18-8;

Wikipedia link : https://en.wikipedia.org/wiki/Tranexamic acid;

Codes EINECS : 214-818-2;

Is substance : O;

UNII : 6T84R30KC1;

InChIKey : GYDJEQRTZSCIOI-LJGSYFOKSA-N;

Details

Origin ID

D014148;

UMLS CUI

C0040613;

ATC code(s)
- tranexamic acid [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Transaminitis [NCIt concept]
- Transaminitis [MedDRA LLT]
CISMeF manual mappings
- Tranexamic acid (substance) [SNOMED CT concept]
- Tranexamic acid adverse reaction (disorder) [SNOMED CT concept]
- tranexamic acid [Substance BNPC]
Pharmacological action(s)
- antifibrinolytic agents [MeSH Descriptor]
Record concept(s)
- KABI 2161 [MeSH concept]
- amchafibrin [MeSH concept]
- anvitoff [MeSH concept]
- cyklokapron [MeSH concept]
- exacyl [MeSH concept]
- spotof [MeSH concept]
- tranexamic acid [MeSH concept]
- transamin [MeSH concept]
- ugurol [MeSH concept]
Related MeSH Supplementary Concept(s)
- 4-aminomethylcyclohexanecarbonyl-O-2-bromobenzyloxycarbonyltyrosine 4-acetylanilide [MeSH Supplementary Concept]
- PKSI 527 [MeSH Supplementary Concept]
- cetraxate [MeSH Supplementary Concept]
- cetraxate benzyl ester [MeSH Supplementary Concept]
- cis-4-aminomethylcyclohexane-1-carboxylic acid [MeSH Supplementary Concept]
- tranexamic acid isobenzedrine ester [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing tranexamic acid (medicinal product) [SNOMED CT concept]
- Tranexamic Acid [NCIt concept]
- Tranexamic acid [ICD-11 Extension code]
- Tranexamic acid (substance) [SNOMED CT concept]
- tranexamic acid [ATC Code]
- tranexamic acid [Substance BNPC]
Validated automatic mappings to BTNT
- tranexamic acid [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients